首页 > 最新文献

Giornale italiano di cardiologia最新文献

英文 中文
[Lipoprotein(a): relationships with atherosclerosis and valvular heart disease, and emerging therapies]. [脂蛋白(a):与动脉粥样硬化和瓣膜性心脏病的关系以及新兴疗法]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-01 DOI: 10.1714/4187.41756
Maurizio Giuseppe Abrignani, Alessandro Maloberti, Stefania Angela Di Fusco, Fabiana Lucà, Arturo Cesaro, Vincenzo Acerbo, Saverio Fabbri, Irene Di Matteo, Antonio F Amico, Pier Luigi Temporelli, Carmine Riccio, Furio Colivicchi, Massimo Grimaldi, Domenico Gabrielli, Fabrizio Oliva

Lipoprotein(a) [Lp(a)] is a well-established cardiovascular risk factor, whose relationship with atherosclerotic disease has been confirmed by epidemiological, genome-wide association, Mendelian randomization, and meta-analysis studies. This association is determined by its pro-atherogenic, pro-thrombotic and pro-inflammatory properties. Lp(a) is the most common monogenic risk factor for atherosclerosis, with a prevalence of about 1 in 5 people. Recently, its etiopathogenetic relationship with calcific and degenerative valvular heart diseases, particularly with aortic and mitral stenosis, has been suspected. It has not yet been demonstrated whether its reduction translates into a lower risk of cardiovascular events. Up to now, Lp(a) has been considered a non-modifiable risk factor, as current lipid-lowering drugs have limited effects on its levels. New specific lipid-lowering therapies with high efficacy in reducing circulating Lp(a) levels are being investigated in randomized trials; however, the effects of this reduction on cardiovascular outcomes are still being studied.

脂蛋白(a)[Lp(a)]是一种公认的心血管风险因素,其与动脉粥样硬化疾病的关系已被流行病学、全基因组关联、孟德尔随机化和荟萃分析研究证实。这种关系是由其促动脉粥样硬化、促血栓形成和促炎症的特性决定的。脂蛋白(a)是动脉粥样硬化最常见的单基因风险因素,发病率约为五分之一。最近,人们怀疑它与钙化性和退行性瓣膜性心脏病,特别是主动脉和二尖瓣狭窄有病因学上的关系。目前尚未证实降低脂蛋白(a)是否会降低心血管事件的风险。迄今为止,脂蛋白(a)一直被认为是不可改变的风险因素,因为目前的降脂药对其水平的影响有限。目前正在随机试验中研究对降低循环中脂蛋白(a)水平有较高疗效的新的特定降脂疗法;然而,这种降低对心血管后果的影响仍在研究之中。
{"title":"[Lipoprotein(a): relationships with atherosclerosis and valvular heart disease, and emerging therapies].","authors":"Maurizio Giuseppe Abrignani, Alessandro Maloberti, Stefania Angela Di Fusco, Fabiana Lucà, Arturo Cesaro, Vincenzo Acerbo, Saverio Fabbri, Irene Di Matteo, Antonio F Amico, Pier Luigi Temporelli, Carmine Riccio, Furio Colivicchi, Massimo Grimaldi, Domenico Gabrielli, Fabrizio Oliva","doi":"10.1714/4187.41756","DOIUrl":"10.1714/4187.41756","url":null,"abstract":"<p><p>Lipoprotein(a) [Lp(a)] is a well-established cardiovascular risk factor, whose relationship with atherosclerotic disease has been confirmed by epidemiological, genome-wide association, Mendelian randomization, and meta-analysis studies. This association is determined by its pro-atherogenic, pro-thrombotic and pro-inflammatory properties. Lp(a) is the most common monogenic risk factor for atherosclerosis, with a prevalence of about 1 in 5 people. Recently, its etiopathogenetic relationship with calcific and degenerative valvular heart diseases, particularly with aortic and mitral stenosis, has been suspected. It has not yet been demonstrated whether its reduction translates into a lower risk of cardiovascular events. Up to now, Lp(a) has been considered a non-modifiable risk factor, as current lipid-lowering drugs have limited effects on its levels. New specific lipid-lowering therapies with high efficacy in reducing circulating Lp(a) levels are being investigated in randomized trials; however, the effects of this reduction on cardiovascular outcomes are still being studied.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 2","pages":"76-87"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139544639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prevalence of circulatory system diseases in Italy]. [意大利循环系统疾病的发病率]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-01 DOI: 10.1714/4195.41819
Roberta Crialesi, Francesco Grippo, Lidia Gargiulo
{"title":"[Prevalence of circulatory system diseases in Italy].","authors":"Roberta Crialesi, Francesco Grippo, Lidia Gargiulo","doi":"10.1714/4195.41819","DOIUrl":"10.1714/4195.41819","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 2","pages":"4S-17S"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139642019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[ANMCO Board of Directors]. [ANMCO 董事会]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-01 DOI: 10.1714/4195.41820
{"title":"[ANMCO Board of Directors].","authors":"","doi":"10.1714/4195.41820","DOIUrl":"10.1714/4195.41820","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 2","pages":"18S"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139642017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[8th Census of cardiology centers in Italy. Italian Association of Hospital Cardiologists (ANMCO). Year 2022]. [第 8 次意大利心脏病中心普查。意大利医院心脏病专家协会(ANMCO)。2022 年]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-01 DOI: 10.1714/4195.41821
Fabrizio Oliva, Giuseppe Di Pasquale, Donata Lucci, Leonardo De Luca, Alessandro Navazio, Roberta Crialesi, Pasquale Perrone Filardi, Massimo Grimaldi, Domenico Gabrielli, Aldo Pietro Maggioni, Furio Colivicchi
{"title":"[8th Census of cardiology centers in Italy. Italian Association of Hospital Cardiologists (ANMCO). Year 2022].","authors":"Fabrizio Oliva, Giuseppe Di Pasquale, Donata Lucci, Leonardo De Luca, Alessandro Navazio, Roberta Crialesi, Pasquale Perrone Filardi, Massimo Grimaldi, Domenico Gabrielli, Aldo Pietro Maggioni, Furio Colivicchi","doi":"10.1714/4195.41821","DOIUrl":"10.1714/4195.41821","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 2","pages":"19S-103S"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139642016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Preface]. [序言]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-01 DOI: 10.1714/4195.41818
Fabrizio Oliva
{"title":"[Preface].","authors":"Fabrizio Oliva","doi":"10.1714/4195.41818","DOIUrl":"10.1714/4195.41818","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 2","pages":"1S-3S"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139642018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Is that what it looks like?] [看起来是这样吗? ]
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-01 DOI: 10.1714/4187.41755
Eugenio Zocca, Francesca Sciarra, Mauro Colletta
{"title":"[Is that what it looks like?]","authors":"Eugenio Zocca, Francesca Sciarra, Mauro Colletta","doi":"10.1714/4187.41755","DOIUrl":"10.1714/4187.41755","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 2","pages":"75"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139546269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[2023 ESC Guidelines for the management of acute coronary syndromes]. [2023年ESC急性冠状动脉综合征治疗指南]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-01 DOI: 10.1714/4191.41785
Robert A Byrne, Xavier Rossello, J J Coughlan, Emanuele Barbato, Colin Berry, Alaide Chieffo, Marc J Claeys, Gheorghe-Andrei Dan, Marc R Dweck, Mary Galbraith, Martine Gilard, Lynne Hinterbuchner, Ewa A Jankowska, Peter Jüni, Takeshi Kimura, Vijay Kunadian, Margret Leosdottir, Roberto Lorusso, Roberto F E Pedretti, Angelos G Rigopoulos, Maria Rubini Gimenez, Holger Thiele, Pascal Vranckx, Sven Wassmann, Nanette Kass Wenger, Borja Ibanez
{"title":"[2023 ESC Guidelines for the management of acute coronary syndromes].","authors":"Robert A Byrne, Xavier Rossello, J J Coughlan, Emanuele Barbato, Colin Berry, Alaide Chieffo, Marc J Claeys, Gheorghe-Andrei Dan, Marc R Dweck, Mary Galbraith, Martine Gilard, Lynne Hinterbuchner, Ewa A Jankowska, Peter Jüni, Takeshi Kimura, Vijay Kunadian, Margret Leosdottir, Roberto Lorusso, Roberto F E Pedretti, Angelos G Rigopoulos, Maria Rubini Gimenez, Holger Thiele, Pascal Vranckx, Sven Wassmann, Nanette Kass Wenger, Borja Ibanez","doi":"10.1714/4191.41785","DOIUrl":"10.1714/4191.41785","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 2","pages":"e1-e112"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139642015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[8th Census of Cardiology Centers in Italy]. [第八次意大利心脏病学中心普查]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-01 DOI: 10.1714/4187.41753
Giuseppe Di Pasquale
{"title":"[8th Census of Cardiology Centers in Italy].","authors":"Giuseppe Di Pasquale","doi":"10.1714/4187.41753","DOIUrl":"10.1714/4187.41753","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 2","pages":"71-72"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139546294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Economic evaluation of a fixed-dose combination (acetylsalicylic acid and rosuvastatin) in the cardiovascular context]. [固定剂量组合(乙酰水杨酸和洛伐他汀)在心血管方面的经济评估]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.1714/4182.41699
Sergio Di Matteo, Sabrin Moumene, Giorgio Lorenzo Colombo, Leonardo De Luca

Background: Cardiovascular diseases pose a significant challenge to the society and healthcare systems, with serious implications in terms of mortality and healthcare expenditure. The treatment of cardiovascular diseases, based on acetylsalicylic acid combined with statins in multi-pill regimens, is characterized by a lower adherence rate among patients compared to the single-pill combination. A potential solution lies in single-pill formulations, drugs that combine two or more active ingredients at a fixed dosage within the same dosage unit.

Methods: In order to assess the potential pharmacoeconomic impact of single-pill treatment, a budget impact model (BIM) was developed, considering the combination of 100 mg acetylsalicylic acid and 5 mg, 10 mg, or 20 mg rosuvastatin.

Results: The use of the single pill, according to the selected scenario, could result in savings in Italy compared to the use of multi-pill at 100%, ranging from € 951 201 in the case of using both single and multi-pill at 50%, to € 1 902 402 in the case of using the single pill exclusively. Sensitivity analysis confirmed the robustness of the results.

Conclusions: The developed BIM allows observing the potential savings that single-pill treatment could generate, linked both to an increase in adherence rates and the consequent improvement in clinical outcomes for patients, as well as the lower cost of medications. The use of single pills represents a promising solution to enhance patient adherence and reduce costs in the management of cardiovascular diseases in Italy.

背景:心血管疾病是社会和医疗系统面临的重大挑战,对死亡率和医疗支出造成严重影响。心血管疾病的治疗以乙酰水杨酸联合他汀类药物的多药方案为基础,与单药组合相比,患者的依从性较低。潜在的解决方案在于单丸制剂,即在同一剂量单位内以固定剂量组合两种或两种以上活性成分的药物:为了评估单药治疗的潜在药物经济学影响,我们建立了一个预算影响模型(BIM),考虑了 100 毫克乙酰水杨酸和 5 毫克、10 毫克或 20 毫克罗伐他汀的组合:结果:根据所选方案,与 100%使用多种药片相比,在意大利使用单一药片可节省费用 951 201 欧元(单一药片和多种药片各占 50%),而只使用单一药片则可节省 1 902 402 欧元。敏感性分析证实了结果的稳健性:通过所开发的 BIM,可以观察到单药丸治疗可能带来的潜在节约,这既与患者依从率的提高和随之而来的临床疗效的改善有关,也与药物成本的降低有关。在意大利,使用单一药片是提高患者依从性和降低心血管疾病治疗成本的一个很有前景的解决方案。
{"title":"[Economic evaluation of a fixed-dose combination (acetylsalicylic acid and rosuvastatin) in the cardiovascular context].","authors":"Sergio Di Matteo, Sabrin Moumene, Giorgio Lorenzo Colombo, Leonardo De Luca","doi":"10.1714/4182.41699","DOIUrl":"10.1714/4182.41699","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases pose a significant challenge to the society and healthcare systems, with serious implications in terms of mortality and healthcare expenditure. The treatment of cardiovascular diseases, based on acetylsalicylic acid combined with statins in multi-pill regimens, is characterized by a lower adherence rate among patients compared to the single-pill combination. A potential solution lies in single-pill formulations, drugs that combine two or more active ingredients at a fixed dosage within the same dosage unit.</p><p><strong>Methods: </strong>In order to assess the potential pharmacoeconomic impact of single-pill treatment, a budget impact model (BIM) was developed, considering the combination of 100 mg acetylsalicylic acid and 5 mg, 10 mg, or 20 mg rosuvastatin.</p><p><strong>Results: </strong>The use of the single pill, according to the selected scenario, could result in savings in Italy compared to the use of multi-pill at 100%, ranging from € 951 201 in the case of using both single and multi-pill at 50%, to € 1 902 402 in the case of using the single pill exclusively. Sensitivity analysis confirmed the robustness of the results.</p><p><strong>Conclusions: </strong>The developed BIM allows observing the potential savings that single-pill treatment could generate, linked both to an increase in adherence rates and the consequent improvement in clinical outcomes for patients, as well as the lower cost of medications. The use of single pills represents a promising solution to enhance patient adherence and reduce costs in the management of cardiovascular diseases in Italy.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 1","pages":"e4-e8"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139478158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes]. [2023年ESC心内膜炎治疗指南]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.1714/4162.41558
Nikolaus Marx, Massimo Federici, Katharina Schütt, Dirk Müller-Wieland, Carolyn Crawford, Björn Eliasson, Christine Espinola-Klein, Laurent Fauchier, Martin Halle, Alexandra Kautzky-Willer, Ekaterini Lambrinou, Maciej Lesiak, Maddalena Lettino, Wilfried Mullens, Bianca Rocca, Naveed Sattar
{"title":"[2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes].","authors":"Nikolaus Marx, Massimo Federici, Katharina Schütt, Dirk Müller-Wieland, Carolyn Crawford, Björn Eliasson, Christine Espinola-Klein, Laurent Fauchier, Martin Halle, Alexandra Kautzky-Willer, Ekaterini Lambrinou, Maciej Lesiak, Maddalena Lettino, Wilfried Mullens, Bianca Rocca, Naveed Sattar","doi":"10.1714/4162.41558","DOIUrl":"10.1714/4162.41558","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 1","pages":"e1-e103"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138884797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Giornale italiano di cardiologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1